Abstract 1880: PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

作者
Gregory L. Moore,Veronica G. Zeng,Juan E. Diaz,Christine Bonzon,Kendra N. Avery,Ruschelle Love,Matthew A. Dragovich,Rumana Rashid,Michael Hackett,Irene Leung,Jing Qi,Charles G. Bakhit,Umesh S. Muchhal,Norman J. Barlow,John R. Desjarlais,Michael Hedvat
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:81 (13_Supplement): 1880-1880 被引量:1
标识
DOI:10.1158/1538-7445.am2021-1880
摘要

Abstract T cells in the tumor micro-environment require TCR/MHC engagement and co-stimulatory receptor engagement to achieve complete activation. Tumor cells lack expression of CD28 ligands, so we hypothesized that activation of CD28 signaling at the T cell/tumor cell interface could enhance anti-tumor activity. We designed PDL1 x CD28 bispecific antibodies that conditionally costimulate CD28 only in the presence of PDL1 and TCR engagement. As PD(L)1 signaling has been shown to directly inhibit CD28 costimulation, this novel bispecific modality has potential to promote CD28 costimulation while simultaneously preventing the suppression of the same signal. We designed a set of stability-optimized anti-CD28 antibodies that can be paired with anti-PDL1 antibodies to engage both PDL1 and CD28 monovalently using Xencor's XmAb® 1+1 bispecific antibody platform. In vitro T cell activation with these bispecifics was measured by T cell proliferation, cytokine production, and cytotoxicity, in co-cultures of human cancer cell lines mixed with primary human CD3-stimulated T cells. In vitro activity was validated in a CMV recall assay measuring CMV+ T cell proliferation of CMV+ PBMC co-cultured with cancer cell lines ectopically treated with pp65-derived NLV-peptide. In vivo activity was determined with hCD28 humanized mice inoculated with MC38 tumors stably expressing hPDL1-antigen. Finally, safety, tolerability, and pharmacodynamics of PDL1 x CD28 were determined in cynomolgus monkeys. PDL1 x CD28 bispecifics were generated by incorporating an anti-PDL1 mAb capable of blocking PDL1-PD1 interaction and anti-CD28 scFv covering a range of affinities. Multiple PDL1 x CD28 antibodies enhanced T cell degranulation, cytokine secretion, and cancer cell cytotoxicity in concert with CD3 stimulation only in the presence of PDL1. PDL1 x CD28 enhanced proliferation of CMV+ T cells recognizing cancer cells loaded with pp65-derived NLV peptide. In hCD28 mice inoculated with MC38 tumors expressing hPDL1, PDL1 x CD28 inhibited tumor growth significantly greater than an anti-PDL1 antibody alone. PDL1 x CD28 was well tolerated in cynomolgus monkeys. PDL1 x CD28 bispecific antibodies show promising anti-tumor activity and warrant further development. Citation Format: Gregory L. Moore, Veronica Zeng, Juan Diaz, Christine Bonzon, Kendra N. Avery, Ruschelle Love, Matthew Dragovich, Rumana Rashid, Michael Hackett, Irene W. Leung, Jing Qi, Charles G. Bakhit, Umesh S. Muchhal, Norman J. Barlow, John R. Desjarlais, Michael Hedvat. PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1880.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
嘤嘤嘤发布了新的文献求助10
1秒前
三千白发生完成签到,获得积分10
1秒前
纳古菌完成签到,获得积分10
2秒前
SG完成签到,获得积分10
2秒前
听话的无极完成签到,获得积分10
2秒前
2秒前
123456完成签到,获得积分10
3秒前
努力小人完成签到,获得积分10
3秒前
4秒前
liang完成签到,获得积分10
4秒前
4秒前
青葙完成签到,获得积分10
5秒前
123456发布了新的文献求助10
6秒前
11NING发布了新的文献求助10
7秒前
Ysk完成签到,获得积分10
7秒前
9秒前
675675发布了新的文献求助10
11秒前
汉堡包的应助被小艾同学采纳,获得10
11秒前
12秒前
15秒前
11NING完成签到,获得积分10
15秒前
15秒前
SCI完成签到,获得积分10
16秒前
Koi发布了新的文献求助10
16秒前
禹hs完成签到,获得积分10
19秒前
吱ing完成签到 ,获得积分10
20秒前
ding的应助被bbb采纳,获得10
20秒前
SCI发布了新的文献求助10
20秒前
ZeSheng完成签到,获得积分10
21秒前
22秒前
22秒前
22秒前
眠龙完成签到 ,获得积分10
23秒前
猪猪侠完成签到,获得积分10
24秒前
24秒前
24秒前
英俊的铭的应助被xxx采纳,获得10
25秒前
水煮电吹风的应助被叶95采纳,获得10
25秒前
ylfs完成签到,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568